Glutamate: The new frontier in pharmacotherapy for cocaine addiction

CNS and Neurological Disorders - Drug Targets

Volumn 7, Issue 5, 2008, Pages 482-491

  Uys, Joachim D ^a   LaLumiere, Ryan T ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Ionotropic; Metabotropic; Nucleus accumbens; Pharmacotherapy; Prefrontal cortex; Receptor

Indexed keywords

(3 ETHYL 2 METHYLQUINOLIN 6 YL) (4 METHOXYCYCLOHEXYL) METHANONE METHANE SULFONATE; 2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; 3 [(2 METHYL 4 THIAZOLYL)ETHYNYL]PYRIDINE; 4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; ACAMPROSATE; ACETYLCYSTEINE; AMANTADINE; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; COCAINE; CYCLOSERINE; GLUTAMIC ACID; IONOTROPIC RECEPTOR; JNJ 16567083; LAMOTRIGINE; MEMANTINE; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR AGONIST; METABOTROPIC RECEPTOR ANTAGONIST; MODAFINIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PLACEBO; TOPIRAMATE; UNCLASSIFIED DRUG; AMINO ACID RECEPTOR BLOCKING AGENT; AMINO ACID RECEPTOR STIMULATING AGENT; GLUTAMATE RECEPTOR;

ALCOHOLISM; ALZHEIMER DISEASE; ANXIETY DISORDER; BRAIN REGION; CLINICAL TRIAL; COCAINE DEPENDENCE; DOPAMINERGIC ACTIVITY; DRUG ABUSE; DRUG DOSE COMPARISON; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG PROTEIN BINDING; FRONTAL CORTEX; HEROIN DEPENDENCE; HUMAN; NEUROPATHOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; OPIATE ADDICTION; PROTEIN LOCALIZATION; PSYCHOPHARMACOTHERAPY; RELAPSE; REVIEW; VENTRAL TEGMENTUM; ANIMAL; BRAIN; DRUG EFFECT; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

ANIMALS; BRAIN; COCAINE; COCAINE-RELATED DISORDERS; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; HUMANS; RECEPTORS, GLUTAMATE; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 61549133947     PISSN: 18715273     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152708786927868     Document Type: Review

References (137)

1. Crits-Christoph, P.; Siqueland, L.; Blaine, J.; Frank, A.; Luborsky, L.; Onken, L.S.; Muenz, L.R.; Thase, M.E.; Weiss, R.D.; Gastfriend, D.R.; Woody, G.E.; Barber, J.P.; Butler, S.F.; Daley, D.; Salloum, I.; Bishop, S.; Najavits, L.M.; Lis, J.; Mercer, D.; Griffin, M.L.; Moras, K.; Beck, A.T. Arch. Gen. Psychiatry, 1999, 56, 493.
2. Cheng, R.K.; Ali, Y.M.; Meck, W.H. Neurobiol. Learn. Mem., 2007, 88, 149.
3. Gallop, R.J.; Crits-Christoph, P.; Ten Have, T.R.; Barber, J.P.; Frank, A.; Griffin, M.L.; Thase, M.E. J. Consult. Clin. Psychol., 2007, 75, 95.
4. Heyne, A.; May, T.; Goll, P.; Wolffgramm, J. J. Neural Transm., 2000, 107, 613.
5. Kelley, A.E. Neuron, 2004, 44, 161.
6. Gardner, E.L. Am. J. Addict., 2000, 9, 285.
7. Jaffe, J.H.; Cascella, N.G.; Kumor, K.M.; Sherer, M.A. Psychopharmacology (Berl.), 1989, 97, 59.
8. O'Brien, C.P.; Childress, A.R.; McLellan, A.T.; Ehrman, R. Ann. N.Y. Acad. Sci., 1992, 654, 400.
9. Brown, S.A.; Vik, P.W.; Patterson, T.L.; Grant, I.; Schuckit, M.A. J. Stud. Alcohol, 1995, 56, 538.
10. Epstein, D.H.; Preston, K.L.; Stewart, J.; Shaham, Y. Psychopharmacology (Berl.), 2006, 189, 1.
11. Fuchs, R.A.; Evans, K.A.; Parker, M.C.; See, R.E. Psychopharmacology (Berl.), 2004, 176, 459.
12. Fuchs, R.A.; Eaddy, J.L.; Su, Z.I.; Bell, G.H. Eur. J. Neurosci., 2007, 26, 487.
13. Cornish, J.L.; Kalivas, P.W. J. Neurosci., 2000, 20, RC89.
14. Shaham, Y.; Erb, S.; Stewart, J. Brain Res. Brain Res. Rev., 2000, 33, 13.
15. Fuchs, R.A.; Branham, R.K.; See, R.E. J. Neurosci., 2006, 26, 3584.
16. Belin, D.; Everitt, B.J. Neuron, 2008, 57, 432.
17. Di Chiara, G. Behav. Brain Res., 2002, 137, 75.
18. Schultz, W. Neuron, 2002, 36, 241.
19. Maldonado, R.; Robledo, P.; Chover, A.J.; Caine, S.B.; Koob, G.F. Pharmacol. Biochem. Behav., 1993, 45, 239.
20. Pulvirenti, L.; Maldonado-Lopez, R.; Koob, G.F. Brain Res., 1992, 594, 327.
21. Mogenson, G.J.; Jones, D.L.; Yim, C.Y. Prog. Neurobiol., 1980, 14, 69.
22. Kelley, A.E. Neurosci. Biobehav. Rev., 2004, 27, 765.
23. Kalivas, P.W.; O'Brien, C. Neuropsychopharmacology, 2008, 33, 166.
24. Bachtell, R.K.; Whisler, K.; Karanian, D.; Self, D.W. Psychopharmacology (Berl.), 2005, 183, 41.
25. Anderson, S.M.; Bari, A.A.; Pierce, R.C. Psychopharmacology (Berl.), 2003, 168, 132.
26. Anderson, S.M.; Schmidt, H.D.; Pierce, R.C. Neuropsychopharmacology, 2006, 31, 1452.
27. Schmidt, H.D.; Pierce, R.C. Neuroscience, 2006, 142, 451.
28. McFarland, K.; Kalivas, P.W. J. Neurosci., 2001, 21, 8655.
29. Peters, J.; Kalivas, P.W. Psychopharmacology (Berl.), 2006, 186, 143.
30. Ping, A.; Xi, J.; Prasad, B.M.; Wang, M.H.; Kruzich, P.J. Brain Res., 2008, 1215, 173.
31. Di Ciano, P.; Everitt, B.J. J. Neurosci., 2004, 24, 7167.
32. Di Ciano, P. Behav. Neurosci., 2008, 122, 129.
33. McFarland, K.; Lapish, C.C.; Kalivas, P.W. J. Neurosci., 2003, 23, 3531.
34. McFarland, K.; Davidge, S.B.; Lapish, C.C.; Kalivas, P.W. J. Neurosci., 2004, 24, 1551.
35. Baker, D.A.; McFarland, K.; Lake, R.W.; Shen, H.; Tang, X.C.; Toda, S.; Kalivas, P.W. Nat. Neurosci., 2003, 6, 743.
36. Kalivas, P.W.; McFarland, K.; Bowers, S.; Szumlinski, K.; Xi, Z.X.; Baker, D. Ann. N.Y. Acad. Sci., 2003, 1003, 169.
37. Moran, M.M.; McFarland, K.; Melendez, R.I.; Kalivas, P.W.; Seamans, J.K. J. Neurosci., 2005, 25, 6389.
38. Baker, D.A.; Xi, Z.X.; Shen, H.; Swanson, C.J.; Kalivas, P.W. J. Neurosci., 2002, 22, 9134.
39. Carr, D.B.; Sesack, S.R. J. Neurosci., 2000, 20, 3864.
40. Steketee, J.D. Crit. Rev. Neurobiol., 2005, 17, 69.
41. Kalivas, P.W.; Lalumiere, R.T.; Knackstedt, L.; Shen, H. Neuropharmacology, 2008, 16, [Epub ahead of print].
42. Sun, W.; Akins, C.K.; Mattingly, A.E.; Rebec, G.V. Neuropsychopharmacology, 2005, 30, 2073.
43. Madayag, A.; Lobner, D.; Kau, K.S.; Mantsch, J.R.; Abdulhameed, O.; Hearing, M.; Grier, M.D.; Baker, D.A. J. Neurosci., 2007, 27, 13968.
44. LaRowe, S.D.; Myrick, H.; Hedden, S.; Mardikian, P.; Saladin, M.; McRae, A.; Brady, K.; Kalivas, P.W.; Malcolm, R. Am. J. Psychiatry, 2007, 164, 1115.
45. Mardikian, P.N.; LaRowe, S.D.; Hedden, S.; Kalivas, P.W.; Malcolm, R.J. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2007, 31, 389.
46. Dingledine, R.; Borges, K.; Bowie, D.; Traynelis, S.F. Pharmacol. Rev., 1999, 51, 7.
47. Szumlinski, K.K.; Ary, A.W.; Lominac, K.D. Biochem. Pharmacol., 2008, 75, 112.
48. Nicoletti, F.; Battaglia, G.; Storto, M.; Ngomba, R.T.; Iacovelli, L.; Arcella, A.; Gradini, R.; Sale, P.; Rampello, L.; De Vita, T.; Di Marco, R.; Melchiorri, D.; Bruno, V. Psychoneuroendocrinology, 2007, 32(Suppl 1), S40.
49. Pierce, R.C.; Bell, K.; Duffy, P.; Kalivas, P.W. J. Neurosci., 1996, 16, 1550.
50. Zhang, X.; Lee, T.H.; Davidson, C.; Lazarus, C.; Wetsel, W.C.; Ellinwood, E.H. Neuropsychopharmacology, 2007, 32, 377.
51. Lau, C.G.; Zukin, R.S. Nat. Rev. Neurosci., 2007, 8, 413.
52. Sun, X.; Zhao, Y.; Wolf, M.E. J. Neurosci., 2005, 25, 7342.
53. Boudreau, A.C.; Reimers, J.M.; Milovanovic, M.; Wolf, M.E. J. Neurosci., 2007, 27, 10621.
54. Boudreau, A.C.; Wolf, M.E. J. Neurosci., 2005, 25, 9144.
55. Conrad, K.L.; Tseng, K.Y.; Uejima, J.L.; Reimers, J.M.; Heng, L.J.; Shaham, Y.; Marinelli, M.; Wolf, M.E. Nature, 2008, 454, 118.
56. Soyka, M.; Roesner, S. Expert Opin. Pharmacother., 2006, 7, 2341.
57. Green, A.I.; Noordsy, D.L.; Brunette, M.F.; O'Keefe, C. J. Subst. Abuse Treat., 2008, 34, 61.
58. Wobrock, T.; Soyka, M. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2008, 32(6), 1375.
59. McGeehan, A.J.; Olive, M.F. Behav. Pharmacol., 2006, 17, 363.
60. Bowers, M.S.; Chen, B.T.; Chou, J.K.; Osborne, M.P.; Gass, J.T.; See, R.E.; Bonci, A.; Janak, P.H.; Olive, M.F. Psychopharmacology (Berl.), 2007, 195, 397.
61. Latini, G.; Verrotti, A.; Manco, R.; Scardapane, A.; Del Vecchio, A.; Chiarelli, F. Mini Rev. Med. Chem., 2008, 8, 10.
62. Rogawski, M.A.; Loscher, W. Nat. Rev. Neurosci., 2004, 5, 553.
63. Le Foll, B.; Justinova, Z.; Wertheim, C.E.; Barnes, C.; Goldberg, S.R. Behav. Pharmacol., 2008, 19, 13.
64. Kampman, K.M.; Pettinati, H.; Lynch, K.G.; Dackis, C.; Sparkman, T.; Weigley, C.; O'Brien, C.P. Drug Alcohol Depend., 2004, 75, 233.
65. Leach, M.J.; Marden, C.M.; Miller, A.A. Epilepsia, 1986, 27, 490.
66. Wang, S.J.; Huang, C.C.; Hsu, K.S.; Tsai, J.J.; Gean, P.W. Synapse, 1996, 24, 248.
67. Lee, C.Y.; Fu, W.M.; Chen, C.C.; Su, M.J.; Liou, H.H. Epilepsia, 2008, 49, 888.
68. Brown, E.S.; Perantie, D.C.; Dhanani, N.; Beard, L.; Orsulak, P.; Rush, A. J. J. Affect. Disord., 2006, 93, 219.
69. Margolin, A.; Avants, S.K.; DePhilippis, D.; Kosten, T.R. Am. J. Drug Alcohol Abuse, 1998, 24, 85.
70. Norberg, M.M.; Krystal, J.H.; Tolin, D.F. Biol. Psychiatry, 2008, 63, 1118.
71. Botreau, F.; Paolone, G.; Stewart, J. Behav. Brain Res., 2006, 172, 173.
72. Kelley, J.B.; Anderson, K.L.; Itzhak, Y. Neuroreport, 2007, 18, 777.
73. Parsons, C.G.; Stoffler, A.; Danysz, W. Neuropharmacology, 2007, 53, 699.
74. Vosburg, S.K.; Hart, C.L.; Haney, M.; Foltin, R.W. Drug Alcohol Depend., 2005, 79, 257.
75. Collins, E.D.; Vosberg, S.K.; Ward, A.S.; Haney, M.; Foltin, R.W. Exp. Clin. Psychopharmacol., 2007, 15, 228.
76. Maldonado, C.; Rodriguez-Arias, M.; Castillo, A.; Aguilar, M.A.; Minarro, J. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2007, 31, 932.
77. Newman, J.L.; Beardsley, P.M. Psychopharmacology (Berl.), 2006, 185, 142.
78. Baldessarini, R.J.; Lipinski, J.F.; Chace, K.V. Biochem. Pharmacol., 1972, 21, 77.
79. Herblin, W.F. Biochem. Pharmacol., 1972, 21, 1993.
80. Stoof, J.C.; Booij, J.; Drukarch, B.; Wolters, E.C. Eur. J. Pharmacol., 1992, 213, 439.
81. Klockgether, T.; Turski, L. Ann. Neurol., 1990, 28, 539.
82. King, G.R.; Joyner, C.; Ellinwood, E.H., Jr. Pharmacol. Biochem. Behav., 1994, 47, 451.
83. Kampman, K.M.; Volpicelli, J.R.; Alterman, A.I.; Cornish, J.; O'Brien, C.P. Am. J. Psychiatry, 2000, 157, 2052.
84. Alterman, A.I.; Droba, M.; Antelo, R.E.; Cornish, J.W.; Sweeney, K.K.; Parikh, G.A.; O'Brien, C.P. Drug Alcohol Depend., 1992, 31, 19.
85. Kampman, K.; Volpicelli, J.R.; Alterman, A.; Cornish, J.; Weinrieb, R.; Epperson, L.; Sparkman, T.; O'Brien, C.P. Drug Alcohol Depend., 1996, 41, 25.
86. Weddington, W.W., Jr.; Brown, B.S.; Haertzen, C.A.; Hess, J.M.; Mahaffey, J.R.; Kolar, A.F.; Jaffe, J.H. Am. J. Drug Alcohol Abuse, 1991, 17, 137.
87. Ballon, J.S.; Feifel, D. J. Clin. Psychiatry, 2006, 67, 554.
88. Korotkova, T.M.; Klyuch, B.P.; Ponomarenko, A.A.; Lin, J.S.; Haas, H.L.; Sergeeva, O.A. Neuropharmacology, 2007, 52, 626.
89. Deroche-Gamonet, V.; Darnaudery, M.; Bruins-Slot, L.; Piat, F.; Le Moal, M.; Piazza, P.V. Psychopharmacology (Berl.), 2002, 161, 387.
90. Gold, L.H.; Balster, R.L. Psychopharmacology (Berl.), 1996, 126, 286.
91. Donovan, J.L.; DeVane, C.L.; Malcolm, R.J.; Mojsiak, J.; Chiang, C.N.; Elkashef, A.; Taylor, R.M. Clin. Pharmacokinet., 2005, 44, 753.
92. Dackis, C.A.; Lynch, K.G.; Yu, E.; Samaha, F.F.; Kampman, K.M.; Cornish, J.W.; Rowan, A.; Poole, S.; White, L.; O'Brien, C.P. Drug Alcohol Depend., 2003, 70, 29.
93. Dackis, C.A.; Kampman, K.M.; Lynch, K.G.; Pettinati, H.M.; O'Brien, C.P. Neuropsychopharmacology, 2005, 30, 205.
94. Malcolm, R.; Swayngim, K.; Donovan, J.L.; DeVane, C.L.; Elkashef, A.; Chiang, N.; Khan, R.; Mojsiak, J.; Myrick, D.L.; Hedden, S.; Cochran, K.; Woolson, R.F. Am. J. Drug Alcohol Abuse, 2006, 32, 577.
95. Hart, C.L.; Haney, M.; Vosburg, S.K.; Rubin, E.; Foltin, R.W. Neuropsychopharmacology, 2008, 33, 761.
96. Mitrano, D.A.; Arnold, C.; Smith, Y. Neuroscience, 2008, 154(2), 653.
97. Ary, A.W.; Szumlinski, K.K. Brain Res., 2007, 1184, 295.
98. Chiamulera, C.; Epping-Jordan, M.P.; Zocchi, A.; Marcon, C.; Cottiny, C.; Tacconi, S.; Corsi, M.; Orzi, F.; Conquet, F. Nat. Neurosci., 2001, 4, 873.
99. Xi, Z.X.; Ramamoorthy, S.; Baker, D.A.; Shen, H.; Samuvel, D.J.; Kalivas, P.W. J. Pharmacol. Exp. Ther., 2002, 303, 608.
100. McGeehan, A.J.; Olive, M.F. Synapse, 2003, 47, 240.
101. Paterson, N.E.; Semenova, S.; Gasparini, F.; Markou, A. Psychopharmacology (Berl.), 2003, 167, 257.
102. Kenny, P.J.; Boutrel, B.; Gasparini, F.; Koob, G.F.; Markou, A. Psychopharmacology (Berl.), 2005, 179, 247.
103. Platt, D.M.; Rowlett, J.K.; Spealman, R.D. Psychopharmacology (Berl.), 2008, 200(2), 167.
104. Lea, P.M.T.; Faden, A.I. CNS Drug Rev., 2006, 12, 149.
105. Iso, Y.; Grajkowska, E.; Wroblewski, J.T.; Davis, J.; Goeders, N.E.; Johnson, K.M.; Sanker, S.; Roth, B.L.; Tueckmantel, W.; Kozikowski, A.P. J. Med. Chem., 2006, 49, 1080.
106. Dravolina, O.A.; Danysz, W.; Bespalov, A.Y. Psychopharmacology (Berl.), 2006, 187, 397.
107. Monn, J.A.; Valli, M.J.; Massey, S.M.; Hansen, M.M.; Kress, T.J.; Wepsiec, J.P.; Harkness, A.R.; Grutsch, J.L., Jr.; Wright, R.A.; Johnson, B.G.; Andis, S.L.; Kingston, A.; Tomlinson, R.; Lewis, R.; Griffey, K.R.; Tizzano, J.P.; Schoepp, D.D. J. Med. Chem., 1999, 42, 1027.
108. Imre, G. CNS Drug Rev., 2007, 13, 444.
109. Bossert, J.M.; Busch, R.F.; Gray, S.M. Neuroreport, 2005, 16, 1013.
110. Lu, L.; Uejima, J.L.; Gray, S.M.; Bossert, J.M.; Shaham, Y. Biol. Psychiatry, 2007, 61, 591.
111. Aujla, H.; Martin-Fardon, R.; Weiss, F. Neuropsychopharmacology, 2008, 33, 1818.
112. Cartmell, J.; Monn, J.A.; Schoepp, D.D. J. Pharmacol. Exp. Ther., 1999, 291, 161.
113. Guhan, N.; Lu, B. Trends Neurosci., 2004, 27, 645.
114. Zhang, G.C.; Mao, L.M.; Liu, X.Y.; Parelkar, N.K.; Arora, A.; Yang, L.; Hains, M.; Fibuch, E.E.; Wang, J.Q. Mol. Pharmacol., 2007, 71, 1148.
115. Fourgeaud, L.; Mato, S.; Bouchet, D.; Hemar, A.; Worley, P.F.; Manzoni, O.J. J. Neurosci., 2004, 24, 6939.
116. Swanson, C.J.; Baker, D.A.; Carson, D.; Worley, P.F.; Kalivas, P.W. J. Neurosci., 2001, 21, 9043.
117. Szumlinski, K.K.; Dehoff, M.H.; Kang, S.H.; Frys, K.A.; Lominac, K.D.; Klugmann, M.; Rohrer, J.; Griffin, W. 3rd; Toda, S.; Champtiaux, N.P.; Berry, T.; Tu, J.C.; Shealy, S.E.; During, M.J.; Middaugh, L.D.; Worley, P.F.; Kalivas, P.W. Neuron, 2004, 43, 401.
118. Lominac, K.D.; Oleson, E.B.; Pava, M.; Klugmann, M.; Schwarz, M.K.; Seeburg, P.H.; During, M.J.; Worley, P.F.; Kalivas, P.W.; Szumlinski, K.K. J. Neurosci., 2005, 25, 11586.
119. Szumlinski, K.K.; Toda, S.; Middaugh, L.D.; Worley, P.F.; Kalivas, P.W. Ann. N.Y. Acad. Sci., 2003, 1003, 468.
120. Shiraishi, Y.; Mizutani, A.; Mikoshiba, K.; Furuichi, T. Mol. Cell Neurosci., 2003, 22, 188.
121. Szumlinski, K.K.; Lominac, K.D.; Kleschen, M.J.; Oleson, E.B.; Dehoff, M.H.; Schwarz, M.K.; Seeburg, P.H.; Worley, P.F.; Kalivas, P.W. Genes Brain Behav., 2005, 4, 273.
122. Sala, C.; Piech, V.; Wilson, N.R.; Passafaro, M.; Liu, G.; Sheng, M. Neuron, 2001, 31, 115.
123. Robinson, T.E.; Kolb, B. Neuropharmacology, 2004, 47(Suppl 1), 33.
124. Sawada, G.A.; Barsuhn, C.L.; Lutzke, B.S.; Houghton, M.E.; Padbury, G.E.; Ho, N.F.; Raub, T.J. J. Pharmacol. Exp. Ther., 1999, 288, 1317.
125. Wu, D.; Pardridge, W.M. Proc. Natl. Acad. Sci. USA, 1999, 96, 254.
126. LaLumiere, R.T.; Kalivas, P.W. J. Neurosci., 2008, 28, 3170.
127. Melendez, R.I.; Hicks, M.P.; Cagle, S.S.; Kalivas, P.W. Alcohol Clin. Exp. Res., 2005, 29, 326.
128. Zhou, W.; Kalivas, P.W. Biol. Psychiatry, 2008, 63, 338.
129. Mann, K.; Lehert, P.; Morgan, M.Y. Alcohol Clin. Exp. Res., 2004, 28, 51.
130. Boothby, L.A.; Doering, P.L. Clin. Ther., 2005, 27, 695.
131. Rubio, G.; Ponce, G.; Jimenez-Arriero, M.A.; Palomo, T.; Manzanares, J.; Ferre, F. Pharmacopsychiatry, 2004, 37, 37.
132. Johnson, B.A.; Ait-Daoud, N.; Akhtar, F.Z.; Ma, J.Z. Arch. Gen. Psychiatry, 2004, 61, 905.
133. Rubio, G.; Lopez-Munoz, F.; Alamo, C. Bipolar Disord., 2006, 8, 289.
134. Khazaal, Y.; Cornuz, J.; Bilancioni, R.; Zullino, D.F. Psychiatry Clin. Neurosci., 2006, 60, 384.
135. Akhondzadeh, S.; Hampa, A.D. Fundam. Clin. Pharmacol., 2005, 19, 601.
136. Krupitsky, E.M.; Rudenko, A.A.; Burakov, A.M.; Slavina, T.Y.; Grinenko, A.A.; Pittman, B.; Gueorguieva, R.; Petrakis, I.L.; Zvartau, E.E.; Krystal, J.H. Alcohol Clin. Exp. Res., 2007, 31, 604.
137. Bisaga, A.; Comer, S.D.; Ward, A.S.; Popik, P.; Kleber, H.D.; Fischman, M.W. Psychopharmacology (Berl.), 2001, 157, 1.